0001558370-24-002037.txt : 20240228 0001558370-24-002037.hdr.sgml : 20240228 20240228171627 ACCESSION NUMBER: 0001558370-24-002037 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 24696901 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 10-K/A 1 hrmy-20231231x10ka.htm 10-K/A
0001802665FYtrue0001802665hrmy:SandipKapadiaMemberhrmy:OriginalPlanMember2023-12-310001802665hrmy:SandipKapadiaMemberhrmy:ModifiedPlanMember2023-12-310001802665hrmy:JeffreyDierksMember2023-12-310001802665hrmy:SandipKapadiaMemberhrmy:OriginalPlanMember2023-10-012023-12-310001802665hrmy:SandipKapadiaMemberhrmy:ModifiedPlanMember2023-10-012023-12-3100018026652023-10-012023-12-310001802665hrmy:SandipKapadiaMember2023-10-012023-12-310001802665hrmy:JeffreyDierksMember2023-10-012023-12-3100018026652023-06-3000018026652024-02-1600018026652023-01-012023-12-31xbrli:sharesiso4217:USD

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No.1)

(Mark One)

☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2023

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to

Commission File Number: 001-39450

HARMONY BIOSCIENCES HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

​

​

​

Delaware

82-2279923

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA

19462

(Address of principal executive offices)

(Zip Code)

​

​

​

(484) 539-9800

(Registrant’s telephone number, including area code)

​

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

​

​

​

​

Trading

​

Name of each exchange

Title of each class

    

Symbol(s)

    

on which registered

Common Stock, par value $0.00001 value per share

​

HRMY

​

The Nasdaq Stock Market LLC

​

​

​

​

(Nasdaq Global Market)

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

​

​

​

​

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

​

​

Emerging growth company

☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting stock held by non-affiliates of the Registrant, as of June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, was $1,174.5 million. As of February 16, 2024, the registrant had 56,769,081 shares of common stock, $0.00001 par value per share, outstanding.

​

Auditor Firm ID: 34Auditor Name: Deloitte & Touche LLPAuditor Location: Philadelphia, Pennsylvania

​

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement relating to its 2024 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2023, are incorporated herein by reference in Part III where indicated.

​

​

Explanatory Note

Harmony Biosciences Holdings, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was originally filed with the Securities and Exchange Commission (the “SEC”) on February 22, 2024 (the “Original Filing”). This Amendment is being filed to revise Part II “Item 9B. Other Information” by adding Rule 10b5-1 trading arrangements entered into or modified by certain of our officers during the quarter ended December 31, 2023.

In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (“Exchange Act”), new certifications of our principal executive officer and principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. The Company is also not including new certifications under Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) (Section 906 of the Sarbanes-Oxley Act of 2002), as no financial statements are being filed with this Amendment.

This Amendment does not otherwise change or update any of the disclosures set forth in the Original Form 10-K and does not otherwise reflect any events occurring after the filing of the Original Form 10-K. No changes have been made to the financial statements of the Company as contained in the Original Filing. Accordingly, the Amendment should be read in conjunction with the Original Form 10-K and the Company’s filings made with the SEC subsequent to the filing of the Original Form 10-K. Capitalized terms used herein and not otherwise defined are defined as set forth in the Original Form 10-K.

​

​

​

2

​

Item 9B. Other Information.

(a) None.

(b) On November 2, 2023, Sandip Kapadia, Chief Financial Officer and Chief Administrative Officer of the Company, modified a Rule 10b5-1 trading arrangement, originally adopted on February 22, 2023, to change the amount of shares to be sold related to the exercise of options under the plan. The modified plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 30,000 shares of the Company’s common stock until April 3, 2024. On November 2, 2023, Mr. Kapadia also adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 55,000 shares of the Company’s common stock related to the exercise of options beginning on April 4, 2024 and until December 30, 2024.

On December 7, 2023, Jeffrey Dierks, Chief Commercial Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 16,097 shares of the Company’s common stock until June 30, 2024 related to the exercise of options.

During the quarter ended December 31, 2023, no director or officer of the Company terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

​

​

​

3

​

PART IV

Item 15. Exhibits, Financial Statement Schedules.

(a)(3) Exhibits.

The documents set forth below are filed herewith or incorporated herein by reference to the location indicated.

EXHIBIT INDEX

Exhibit

​

​

​

Incorporated by Reference

​

Filed

No.

​

Exhibit Description

​

Form

​

Date

​

Number

​

Herewith

​

​

​

​

​

​

​

​

​

​

​

31.1

​

Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

​

​

​

​

​

​

​

X

​

​

​

​

​

​

​

​

​

​

​

31.2

​

Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

​

​

​

​

​

​

​

X

​

​

​

​

​

​

​

​

​

​

​

104

​

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

​

​

​

​

​

​

​

X

​

​

​

​

​

​

​

​

​

​

​

​

​

​

4

​

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​

​

​

​

​

HARMONY BIOSCIENCES HOLDINGS, INC.

​

​

​

​

By:

/s/ Jeffrey M. Dayno

​

Name:

Jeffrey M. Dayno

​

Title:

President, Chief Executive Officer and Director (principal executive officer)

​

​

​

​

Date: February 28, 2024

​

​

5

 EX-31.1 2 hrmy-20231231xex31d1.htm EX-31.1

Exhibit 31.1

​

Certification of Principal Executive Officer

​

I, Jeffrey M. Dayno, certify that:

​

1.

I have reviewed this Annual Report on Form 10-K/A of Harmony Biosciences Holdings, Inc.; and

​

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

​

​

​

​

​

​

​

Date:

February 28, 2024

​

By:

/s/ Jeffrey M. Dayno

​

​

​

​

Name:

Jeffrey M. Dayno

​

​

President, Chief Executive Officer and Director

(Principal Executive Officer)

​

​

 EX-31.2 3 hrmy-20231231xex31d2.htm EX-31.2

Exhibit 31.2

​

Certification of Principal Financial Officer

​

I, Sandip Kapadia, certify that:

​

1.

I have reviewed this Annual Report on Form 10-K/A of Harmony Biosciences Holdings, Inc.; and

​

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

​

​

​

​

Date:

February 28, 2024

​

By:

/s/ Sandip Kapadia

​

​

​

​

Name:

Sandip Kapadia

​

​

Chief Financial Officer and Chief Administrative Officer

(Principal Financial Officer and Accounting Officer)

​

​

 EX-101.SCH 4 hrmy-20231231.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 hrmy-20231231_def.xml EX-101.DEF EX-101.LAB 6 hrmy-20231231_lab.xml EX-101.LAB EX-101.PRE 7 hrmy-20231231_pre.xml EX-101.PRE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Feb. 16, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39450    
Entity Registrant Name HARMONY BIOSCIENCES HOLDINGS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-2279923    
Entity Address, Postal Zip Code 19462    
Entity Address, Address Line One 630 W.    
Entity Address, Address Line Two Germantown Pike    
Entity Address, Address Line Three Suite 215    
Entity Address, City or Town Plymouth Meeting    
Entity Address, State or Province PA    
City Area Code 484    
Local Phone Number 539-9800    
Title of 12(b) Security Common Stock, par value $0.00001 value per share    
Trading Symbol HRMY    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 1,174.5
Entity Common Stock, Shares Outstanding   56,769,081  
Entity Central Index Key 0001802665    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Amendment Flag true    
Amendment Description Harmony Biosciences Holdings, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was originally filed with the Securities and Exchange Commission (the “SEC”) on February 22, 2024 (the “Original Filing”). This Amendment is being filed to revise Part II “Item 9B. Other Information” by adding Rule 10b5-1 trading arrangements entered into or modified by certain of our officers during the quarter ended December 31, 2023.    
Auditor Name Deloitte & Touche LLP    
Auditor Firm ID 34    
Auditor Location Philadelphia, Pennsylvania    
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2023
shares
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Sandip Kapadia [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement On November 2, 2023, Sandip Kapadia, Chief Financial Officer and Chief Administrative Officer of the Company, modified a Rule 10b5-1 trading arrangement, originally adopted on February 22, 2023, to change the amount of shares to be sold related to the exercise of options under the plan. The modified plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 30,000 shares of the Company’s common stock until April 3, 2024. On November 2, 2023, Mr. Kapadia also adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 55,000 shares of the Company’s common stock related to the exercise of options beginning on April 4, 2024 and until December 30, 2024.
Name Sandip Kapadia
Title Chief Financial Officer and Chief Administrative Officer
Jeffrey Dierks [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On December 7, 2023, Jeffrey Dierks, Chief Commercial Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 16,097 shares of the Company’s common stock until June 30, 2024 related to the exercise of options.
Name Jeffrey Dierks
Title Chief Commercial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 7, 2023
Aggregate Available 16,097
Trd Arr Expiration Date June 30, 2024
Modified Plan [Member] | Sandip Kapadia [Member]  
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 22, 2023
Aggregate Available 30,000
Rule 10b5-1 Arrangement Modified true
Trd Arr Expiration Date April 3, 2024
Trd Arr Modified Date November 2, 2023
Original Plan [Member] | Sandip Kapadia [Member]  
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted true
Adoption Date November 2, 2023
Aggregate Available 55,000
Trd Arr Expiration Date December 30, 2024
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 11 51 1 false 4 0 false 2 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 2 false false All Reports Book All Reports hrmy-20231231.xsd hrmy-20231231_def.xml hrmy-20231231_lab.xml hrmy-20231231_pre.xml hrmy-20231231x10ka.htm http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hrmy-20231231x10ka.htm": { "nsprefix": "hrmy", "nsuri": "http://www.harmonybiosciences.com/20231231", "dts": { "schema": { "local": [ "hrmy-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] }, "definitionLink": { "local": [ "hrmy-20231231_def.xml" ] }, "labelLink": { "local": [ "hrmy-20231231_lab.xml" ] }, "presentationLink": { "local": [ "hrmy-20231231_pre.xml" ] }, "inline": { "local": [ "hrmy-20231231x10ka.htm" ] } }, "keyStandard": 48, "keyCustom": 3, "axisStandard": 2, "axisCustom": 0, "memberStandard": 0, "memberCustom": 4, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 11, "entityCount": 1, "segmentCount": 4, "elementCount": 141, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 40, "http://xbrl.sec.gov/ecd/2023": 17 }, "report": { "R1": { "role": "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_RbooptX6W0KZ8Jqww0XlYA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hrmy-20231231x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_RbooptX6W0KZ8Jqww0XlYA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hrmy-20231231x10ka.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "2", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_X6pgl09UoUyeCV2-UzPLsA", "name": "ecd:Rule10b51ArrTrmntdFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hrmy-20231231x10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_X6pgl09UoUyeCV2-UzPLsA", "name": "ecd:Rule10b51ArrTrmntdFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "hrmy-20231231x10ka.htm", "first": true, "unique": true } } }, "tag": { "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r39" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r45" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r45" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r45" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r45" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r9", "r21", "r31", "r57" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r12", "r24", "r34", "r60" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r45" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r52" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r16", "r25", "r35", "r52", "r61", "r65", "r73" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r71" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r3", "r4", "r17" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "auth_ref": [ "r3", "r4", "r17" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "auth_ref": [ "r3", "r4", "r17" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r68" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r69" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r64" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r64" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r67" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r66" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r65" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r65" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r43" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r44" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r44" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r49" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r48" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r50" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r47" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r3", "r4", "r17" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "terseLabel": "Document Financial Statement Error Correction", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r3", "r4", "r17", "r53" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r38" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "verboseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line3", "terseLabel": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r78" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r79" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r46" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r9", "r21", "r31", "r57" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r6", "r18", "r28", "r54" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r52" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r13", "r25", "r35", "r61" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r13", "r25", "r35", "r61" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r13", "r25", "r35", "r61" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r13", "r25", "r35", "r61" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r13", "r25", "r35", "r61" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r3", "r4", "r17" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r16", "r25", "r35", "r52", "r61", "r65", "r73" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r71" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r5", "r77" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r5", "r77" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r5", "r77" ] }, "hrmy_JeffreyDierksMember": { "xbrltype": "domainItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "JeffreyDierksMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Jeffrey Dierks, Chief Commercial Officer of the Company.", "label": "Jeffrey Dierks [Member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r44" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r44" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r64" ] }, "hrmy_ModifiedPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "ModifiedPlanMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the Modified Plan.", "label": "Modified Plan [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r72" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r45" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r44" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r13", "r25", "r35", "r52", "r61" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r42" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r41" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r52" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r72" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r72" ] }, "hrmy_OriginalPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "OriginalPlanMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the original plan adopted.", "label": "Original Plan [Member]" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r44" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r11", "r23", "r33", "r59" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r14", "r26", "r36", "r62" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r14", "r26", "r36", "r62" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r40" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r43" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r43" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r42" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r52" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r45" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r41" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r40" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r40" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r6", "r18", "r28", "r54" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r7", "r19", "r29", "r55" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r8", "r20", "r30", "r56" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r15", "r27", "r37", "r63" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r72" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r72" ] }, "hrmy_Rule10b51ArrangementModified": { "xbrltype": "booleanItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "Rule10b51ArrangementModified", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Rule 10b5-1 Arrangement Modified" } } }, "auth_ref": [] }, "hrmy_SandipKapadiaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "SandipKapadiaMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Sandip Kapadia, Chief Financial Officer and Chief Administrative Officer of the Company.", "label": "Sandip Kapadia [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security12b Title", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r10", "r22", "r32", "r58" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r51" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r43" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r50" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r71" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r73" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.harmonybiosciences.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r74" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r75" ] }, "hrmy_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Trd Arr Expiration Date" } } }, "auth_ref": [] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r73" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r73" ] }, "hrmy_TrdArrModifiedDate": { "xbrltype": "stringItemType", "nsuri": "http://www.harmonybiosciences.com/20231231", "localname": "TrdArrModifiedDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Trd Arr Modified Date" } } }, "auth_ref": [] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r76" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r74" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r70" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r43": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r44": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r45": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r46": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r47": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r48": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r49": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r50": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r51": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r52": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r53": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r54": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r55": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r56": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r57": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r58": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r59": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r60": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r61": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r62": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r63": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r64": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r65": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r66": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r67": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r68": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r69": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r70": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r71": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r72": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r73": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r74": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r75": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r76": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r77": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r78": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r79": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" } } } ZIP 18 0001558370-24-002037-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-002037-xbrl.zip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� M3)H !4 ( !BP4 &AR;7DM,C R,S$R,S%?9&5F+GAM;%!+ M 0(4 Q0 ( R*7%BK"&*YH0H .R> 5 " 403 !H M2TR,#(S,3(S,5]P&UL4$L! M A0#% @ #(I<6 *#2$TS*@ @EH! !8 ( !128 &AR M;7DM,C R,S$R,S%X,3!K82YH=&U02P$"% ,4 " ,BEQ8G)_,!G8% #\ M(0 & @ &L4 :')M>2TR,#(S,3(S,7AE>#,Q9#$N:'1M M4$L! A0#% @ #(I<6'I(]6L*!0 A1X !@ ( !6%8 M &AR;7DM,C R,S$R,S%X97@S,60R+FAT;5!+!08 !P ' -@! "86P " ! end XML 19 hrmy-20231231x10ka_htm.xml IDEA: XBRL DOCUMENT 0001802665 hrmy:SandipKapadiaMember hrmy:OriginalPlanMember 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:ModifiedPlanMember 2023-12-31 0001802665 hrmy:JeffreyDierksMember 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:OriginalPlanMember 2023-10-01 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:ModifiedPlanMember 2023-10-01 2023-12-31 0001802665 2023-10-01 2023-12-31 0001802665 hrmy:SandipKapadiaMember 2023-10-01 2023-12-31 0001802665 hrmy:JeffreyDierksMember 2023-10-01 2023-12-31 0001802665 2023-06-30 0001802665 2024-02-16 0001802665 2023-01-01 2023-12-31 shares iso4217:USD 0001802665 FY true 10-K/A true 2023-12-31 --12-31 2023 false 001-39450 HARMONY BIOSCIENCES HOLDINGS, INC. DE 82-2279923 630 W. Germantown Pike Suite 215 Plymouth Meeting PA 19462 484 539-9800 Common Stock, par value $0.00001 value per share HRMY NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false false 1174500000 56769081 34 Deloitte & Touche LLP Philadelphia, Pennsylvania Harmony Biosciences Holdings, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was originally filed with the Securities and Exchange Commission (the “SEC”) on February 22, 2024 (the “Original Filing”). This Amendment is being filed to revise Part II “Item 9B. Other Information” by adding Rule 10b5-1 trading arrangements entered into or modified by certain of our officers during the quarter ended December 31, 2023. On November 2, 2023, Sandip Kapadia, Chief Financial Officer and Chief Administrative Officer of the Company, modified a Rule 10b5-1 trading arrangement, originally adopted on February 22, 2023, to change the amount of shares to be sold related to the exercise of options under the plan. The modified plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 30,000 shares of the Company’s common stock until April 3, 2024. On November 2, 2023, Mr. Kapadia also adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to 55,000 shares of the Company’s common stock related to the exercise of options beginning on April 4, 2024 and until December 30, 2024. November 2, 2023 Sandip Kapadia Chief Financial Officer and Chief Administrative Officer true true February 22, 2023 30000 April 3, 2024 November 2, 2023 true 55000 December 30, 2024 <p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On December 7, 2023, Jeffrey Dierks, Chief Commercial Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 16,097 shares of the Company’s common stock until June 30, 2024 related to the exercise of options.</p> December 7, 2023 Jeffrey Dierks Chief Commercial Officer true 16097 June 30, 2024 false false